Interspond, LLC is a Trial Management Organization (TMO) established in 2003 that works with a hybrid network of exclusive and affiliated multi-therapeutic sites across the country. As such, we seek to identify study opportunities for the sites with which we work. Once identified, we query the sites, submit them for consideration for participation, facilitate the study start-up process and negotiate the contract and budget.
Having developed the first TMO in the industry more than 20 years ago, Interspond founder and President Kathy S. Cox has been in the industry for more than 27 years. Kathy has spent over a quarter of a century building a reputation on integrity, honesty and reliability. Interspond has earned the status of the network of choice for many sponsors, CROs, and sites. Over the past couple of decades, we have established and nurtured relationships with clients and customers. Kathy continues to successfully work this business model today, and clients and customers have come to depend on our leadership.